[Clinical experience with methoxybutropate vs. bromelin in the treatment of female pelvic inflammation].
This study reports the results of a controlled randomized clinical trial performed on 30 young women with PID (Pelvic Inflammatory Disease), using a new anti- inflammatory-analgesic: methoxybutropate. The quali-quantitative symptomatical assessment showed that the improvement of the pain has been more marked and faster with methoxybutropate than hot observed in control group treated with bromeline.
Melis
G B
GB
Istituto di Ginecologia ed Ostertricia, Università degli Studi di Pisa.
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001963:Bromelains / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006139:Guaiacol / Q000031:analogs & derivatives; D006801:Humans; D007052:Ibuprofen / Q000031:analogs & derivatives / Q000627:therapeutic use; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; C020176:metoxibutropate; D006139:Guaiacol; D001963:Bromelains; D007052:Ibuprofen
Esperienza clinica con metossibutropato vs bromelina nel trattamento delle flogosi della pelvi femminile.